Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,558.00    -18.00 (-0.70%)
Bid:
2,560.00
Ask:
2,562.00
Spread: 2.00 (0.078%)
Market Cap: £8.21b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

30 Jun 2022 07:00

RNS Number : 7013Q
Bunzl PLC
30 June 2022
 

30 June 2022

 

BUNZL PRE-CLOSE STATEMENT

 

Bunzl plc, the specialist international distribution and services Group, is updating the market today prior to entering its closed period for the six months ending 30 June 2022.

 

The Group is expected to deliver very strong growth over the period, reflecting the resilience and strength of the Bunzl business model. Group revenue in the first half is expected to increase year-on-year by approximately 16% at actual exchange rates and by 12-13% at constant exchange rates1, with inflation continuing to drive underlying revenue growth and the impact of acquisitions further supplementing growth. Group adjusted operating margin for the first half is expected to be slightly higher than historical annual levels.

 

Across our business areas inflation remains the key driver of performance. Very strong revenue growth has been maintained in North America over the period and negotiations with our largest customer are constructive and ongoing. Continental Europe similarly maintained strong momentum, whilst the UK & Ireland's operating margin continues to see year-on-year improvement alongside very strong base business recovery. Rest of the World's revenue growth has been moderate, with very strong growth in Asia Pacific partially offset by the expected decline in Covid-19 related sales in Latin America.

 

The Group is upgrading its guidance for the year on the basis of very strong revenue growth to date and announced acquisitions. At constant exchange rates the Group now expects very good revenue growth in 2022, driven by good organic revenue growth and the positive contribution of acquisitions announced in the last 12 months. Growth of the base business is expected to be only partially offset by the further normalisation of sales of Covid-19 related products, albeit these are expected to remain ahead of 2019 levels. We continue to expect Group operating margin in 2022 to be slightly higher than historical levels.

 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"Bunzl has delivered another period of strong growth. We continue to demonstrate the strength of our business model, supported by the depth and resilience of our supply chains and the agility of our people who have responded to the inflationary environment so successfully. Our acquisition momentum remains strong, with our active pipeline supported by a strong balance sheet."

 

 

Note:

1. The number of trading days will not have an impact on growth over the period. 

 

 

Enquiries:

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations

Tel: +44 (0)20 7725 5000

Tulchan

Martin Robinson

Olivia Peters

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUGDLUSDDGDC
Date   Source Headline
14th Jul 20214:11 pmRNSDirector/PDMR Shareholding
7th Jul 20219:30 amRNSDirector/PDMR Shareholding
1st Jul 202112:30 pmRNSTotal Voting Rights
24th Jun 20217:00 amRNSTrading Statement
23rd Jun 20218:00 amRNSAdditional Listing
3rd Jun 20211:00 pmRNSDirector/PDMR Shareholding
1st Jun 20211:00 pmRNSTotal Voting Rights
26th May 20219:30 amRNSDirector Declaration
26th May 20218:00 amRNSAdditional Listing
18th May 20217:00 amRNSAcquisition
6th May 202110:40 amRNSDirector/PDMR Shareholding
5th May 20211:15 pmRNSDirector/PDMR Shareholding
5th May 20211:01 pmRNSDirector/PDMR Shareholding
4th May 202110:50 amRNSTotal Voting Rights
4th May 20219:25 amRNSBlock listing Interim Review
22nd Apr 20214:40 pmRNSDirector/PDMR Shareholding
21st Apr 20214:16 pmRNSResult of AGM
21st Apr 20217:00 amRNSTrading Statement
14th Apr 202111:45 amRNSDirector/PDMR Shareholding
12th Apr 20218:43 amRNSDirector/PDMR Shareholding
12th Apr 20218:24 amRNSDirector/PDMR Shareholding
7th Apr 20213:24 pmRNSDirector/PDMR Shareholding
1st Apr 202111:44 amRNSTotal Voting Rights
31st Mar 20215:34 pmRNSDirector/PDMR Shareholding
22nd Mar 20214:30 pmRNSDirector Declaration
17th Mar 20214:27 pmRNSAnnual Financial Report
8th Mar 20215:53 pmRNSDirector/PDMR Shareholding
5th Mar 20211:10 pmRNSDirector/PDMR Shareholding
4th Mar 20215:33 pmRNSDirector/PDMR Shareholding
3rd Mar 202110:00 amRNSDirector Declaration
1st Mar 20212:00 pmRNSTotal Voting Rights
1st Mar 20211:00 pmRNSDirector/PDMR Shareholding
1st Mar 20211:00 pmRNSDividend Declaration
1st Mar 20217:00 amRNSFinal Results
1st Mar 20217:00 amRNSAcquisition
1st Feb 202110:00 amRNSTotal Voting Rights
20th Jan 20217:00 amRNSDirector Declaration
6th Jan 20214:00 pmRNSDirector/PDMR Shareholding
4th Jan 202111:50 amRNSTotal Voting Rights
22nd Dec 20207:00 amRNSDirectorate Change
16th Dec 20208:00 amRNSAdditional Listing
16th Dec 20207:00 amRNSTrading Statement
9th Dec 20208:00 amRNSAdditional Listing
3rd Dec 20209:27 amRNSDirector/PDMR Shareholding
2nd Dec 20208:00 amRNSAdditional Listing
1st Dec 202011:57 amRNSTotal Voting Rights
20th Nov 202012:30 pmRNSDirector Declaration
9th Nov 20207:00 amRNSAcquisition
3rd Nov 20205:18 pmRNSDirector/PDMR Shareholding
2nd Nov 202010:45 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.